These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 31479092)
41. A recent update on the use of microbial transglutaminase for the generation of biotherapeutics. Doti N; Caporale A; Monti A; Sandomenico A; Selis F; Ruvo M World J Microbiol Biotechnol; 2020 Mar; 36(4):53. PubMed ID: 32172335 [TBL] [Abstract][Full Text] [Related]
42. Lipoate-acid ligase a modification of native antibody: Synthesis and conjugation site analysis. Yamazaki S; Shikida N; Takahashi K; Matsuda Y; Inoue K; Shimbo K; Mihara Y Bioorg Med Chem Lett; 2021 Nov; 51():128360. PubMed ID: 34537330 [TBL] [Abstract][Full Text] [Related]
44. A Hexa-rhodium Metallopeptide Catalyst for Site-Specific Functionalization of Natural Antibodies. Ohata J; Ball ZT J Am Chem Soc; 2017 Sep; 139(36):12617-12622. PubMed ID: 28810739 [TBL] [Abstract][Full Text] [Related]
45. Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3-Expressing Liver Cancer by Immuno-PET. Fayn S; King AP; Gutsche NT; Duan Z; Buffington J; Olkowski CP; Fu Y; Hong J; Sail D; Baidoo KE; Swenson RE; Cheloha RW; Ho M; Choyke PL; Escorcia FE J Nucl Med; 2023 Jul; 64(7):1017-1023. PubMed ID: 36997331 [TBL] [Abstract][Full Text] [Related]
46. Site-Specific Conjugation of Metal-Chelating Polymers to Anti-Frizzled-2 Antibodies Le PJ; Miersch S; Forbes MW; Jarvik N; Ku A; Sidhu SS; Reilly RM; Winnik MA Biomacromolecules; 2021 Jun; 22(6):2491-2504. PubMed ID: 33961407 [TBL] [Abstract][Full Text] [Related]
47. Antibody structural integrity of site-specific antibody-drug conjugates investigated by hydrogen/deuterium exchange mass spectrometry. Pan LY; Salas-Solano O; Valliere-Douglass JF Anal Chem; 2015 Jun; 87(11):5669-76. PubMed ID: 25938577 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and evaluation of zirconium-89 labelled and long-lived GLP-1 receptor agonists for PET imaging. Jacobsen CB; Raavé R; Pedersen MØ; Adumeau P; Moreau M; Valverde IE; Bjørnsdottir I; Kristensen JB; Grove MF; Raun K; McGuire J; Goncalves V; Heskamp S; Denat F; Gustafsson M Nucl Med Biol; 2020; 82-83():49-56. PubMed ID: 32000047 [TBL] [Abstract][Full Text] [Related]
49. Engineering Antibodies with C-Terminal Sortase-Mediated Modification for Targeted Nanomedicine. Hashad RA; Lange JL; Tan NCW; Alt K; Hagemeyer CE Methods Mol Biol; 2019; 2033():67-80. PubMed ID: 31332748 [TBL] [Abstract][Full Text] [Related]
50. CMC-modified cellulose biointerface for antibody conjugation. Orelma H; Teerinen T; Johansson LS; Holappa S; Laine J Biomacromolecules; 2012 Apr; 13(4):1051-8. PubMed ID: 22360491 [TBL] [Abstract][Full Text] [Related]
51. Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor. Manjappa AS; Chaudhari KR; Venkataraju MP; Dantuluri P; Nanda B; Sidda C; Sawant KK; Murthy RS J Control Release; 2011 Feb; 150(1):2-22. PubMed ID: 21095210 [TBL] [Abstract][Full Text] [Related]
52. Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with ⁸⁹Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts. ter Weele EJ; Terwisscha van Scheltinga AG; Kosterink JG; Pot L; Vedelaar SR; Lamberts LE; Williams SP; Lub-de Hooge MN; de Vries EG Oncotarget; 2015 Dec; 6(39):42081-90. PubMed ID: 26536664 [TBL] [Abstract][Full Text] [Related]
53. Discovery of two transglutaminases derived from same zymogen for the Streptomyces hygroscopicus and analysis of their formation processes. Cui W; Yang X; Fang Y; Zhou S; Liu S; Du G; Du K; Chen J; Tao G; Zhou Z J Sci Food Agric; 2013 May; 93(7):1711-7. PubMed ID: 23355183 [TBL] [Abstract][Full Text] [Related]
54. Lysine residues of IGF-I are substrates for transglutaminases and modulate downstream IGF-I signalling. Sivaramakrishnan M; Croll TI; Gupta R; Stupar D; Van Lonkhuyzen DR; Upton Z; Shooter GK Biochim Biophys Acta; 2013 Dec; 1833(12):3176-3185. PubMed ID: 24036101 [TBL] [Abstract][Full Text] [Related]
55. Mass spectrometric characterization of transglutaminase based site-specific antibody-drug conjugates. Farias SE; Strop P; Delaria K; Galindo Casas M; Dorywalska M; Shelton DL; Pons J; Rajpal A Bioconjug Chem; 2014 Feb; 25(2):240-50. PubMed ID: 24359082 [TBL] [Abstract][Full Text] [Related]
56. Antibody-dendrimer conjugates: the number, not the size of the dendrimers, determines the immunoreactivity. Wängler C; Moldenhauer G; Eisenhut M; Haberkorn U; Mier W Bioconjug Chem; 2008 Apr; 19(4):813-20. PubMed ID: 18361514 [TBL] [Abstract][Full Text] [Related]